| Authors: |
Desai AP; Department of Urology, University of North Carolina, Chapel Hill, NC, USA., Basak RS; Department of Urology, University of North Carolina, Chapel Hill, NC, USA., Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Sperger J; Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA., Schroeck FR; Section of Urology, White River Junction VA Healthcare System, VT, and Geisel School of Medicine at Dartmouth College, Lebanon, NH, USA., Lipman R; Bladder Cancer Advocacy Network, Bethesda, MD, USA., Chaplin I; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Roberson H; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Lopez P; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Jenkins W; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Gore JL; Department of Urology, University of Washington, Seattle, WA, USA., Kosorok MR; Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA., Smith AB; Department of Urology, University of North Carolina, Chapel Hill, NC, USA. |
